124 related articles for article (PubMed ID: 35567786)
1. Cytomorphometric and flow cytometric analyses using liquid-based cytology materials in subtypes of lung adenocarcinoma.
Tanaka R; Fujiwara M; Sakamoto N; Suzuki H; Tachibana K; Ohtsuka K; Kishimoto K; Kamma H; Shibahara J; Kondo H
Diagn Cytopathol; 2022 Aug; 50(8):394-403. PubMed ID: 35567786
[TBL] [Abstract][Full Text] [Related]
2. Cytological characteristics of histological types of lung cancer by cytomorphometric and flow cytometric analyses using liquid-based cytology materials.
Tanaka R; Fujiwara M; Sakamoto N; Kanno H; Arai N; Tachibana K; Kishimoto K; Anraku M; Shibahara J; Kondo H
Diagn Cytopathol; 2023 Jun; 51(6):356-364. PubMed ID: 36853229
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
[TBL] [Abstract][Full Text] [Related]
4. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
[TBL] [Abstract][Full Text] [Related]
5. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma.
Li Z; Li F; Pan C; He Z; Pan X; Zhu Q; Wu W; Chen L
Lung Cancer; 2021 Apr; 154():69-75. PubMed ID: 33626488
[TBL] [Abstract][Full Text] [Related]
7. Acinar-Predominant Pattern Correlates With Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung.
Lin G; Li H; Kuang J; Tang K; Guo Y; Han A; Xie C
Am J Clin Pathol; 2018 Mar; 149(5):373-378. PubMed ID: 29538611
[TBL] [Abstract][Full Text] [Related]
8. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
[TBL] [Abstract][Full Text] [Related]
10. What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?
Aherne EA; Plodkowski AJ; Montecalvo J; Hayan S; Zheng J; Capanu M; Adusumilli PS; Travis WD; Ginsberg MS
Lung Cancer; 2018 Apr; 118():83-89. PubMed ID: 29572008
[TBL] [Abstract][Full Text] [Related]
11. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
12. Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification.
Hong JH; Park S; Kim H; Goo JM; Park IK; Kang CH; Kim YT; Yoon SH
Korean J Radiol; 2021 Mar; 22(3):464-475. PubMed ID: 33169551
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.
Matsuzawa R; Kirita K; Kuwata T; Umemura S; Matsumoto S; Fujii S; Yoh K; Kojima M; Niho S; Ohmatsu H; Ochiai A; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2016 Apr; 94():1-6. PubMed ID: 26973199
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC
J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
16. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma.
Ercelep O; Alan O; Telli TA; Tuylu TB; Arıkan R; Demircan NC; Simsek ET; Babacan NA; Kaya S; Dane F; Bozkurtlar E; Ones T; Lacin T; Yumuk PF
Tumori; 2021 Jun; 107(3):231-237. PubMed ID: 32878562
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma.
Yotsukura M; Asamura H; Suzuki S; Asakura K; Yoshida Y; Nakagawa K; Sakurai H; Watanabe SI; Motoi N
Lung Cancer; 2020 Jul; 145():158-166. PubMed ID: 32450494
[TBL] [Abstract][Full Text] [Related]
18. Comparison of small biopsy and cytology specimens: Subtyping of pulmonary adenocarcinoma.
Ma C; Zhang L
Cytojournal; 2023; 20():5. PubMed ID: 36895259
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the Study of Invasive Non-mucinous Adenocarcinoma
with Different Pathological Subtypes].
Tang R; Bi L; Xiang B; Ye L; Chen Y; Li G; Zhao G; Huang Y
Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):22-30. PubMed ID: 36792077
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between the new lung adenocarcinoma classification and epidermal growth factor receptor mutation].
Zhang XD; Liu DR
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):640-644. PubMed ID: 30122764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
